Wogonin

Wogonin is a lipid of Polyketides (PK) class. Wogonin is associated with abnormalities such as Hyperlipidemia, Atherosclerosis, Inflammatory disorder, Dermatitis, Atopic and Ischemia. The involved functions are known as Inflammation, Regulation, luciferase activity, store-operated calcium entry and Transcriptional Activation. Wogonin often locates in Cytoplasmic matrix, Pore, Membrane, Protoplasm and Mitochondria. The associated genes with Wogonin are SGK1 gene, ORAI1 gene, STIM1 gene, P4HTM gene and BCL2 gene.

Cross Reference

Introduction

To understand associated biological information of Wogonin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Wogonin?

Wogonin is suspected in Ischemia, Hyperlipidemia, Atherosclerosis, Inflammatory disorder, Dermatitis, Atopic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Wogonin

MeSH term MeSH ID Detail
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Carcinoma D002277 18 associated lipids
Per page 10 20 50 | Total 24

PubChem Associated disorders and diseases

What pathways are associated with Wogonin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Wogonin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Wogonin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Wogonin?

There are no associated biomedical information in the current reference collection.

What genes are associated with Wogonin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Wogonin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Wogonin

Download all related citations
Per page 10 20 50 100 | Total 475
Authors Title Published Journal PubMed Link
Xiao JR et al. Potential therapeutic effects of baicalein, baicalin, and wogonin in ocular disorders. 2014 J Ocul Pharmacol Ther pmid:25280175
Kwak S et al. Vascular barrier protective effects of baicalin, baicalein and wogonin in vitro and in vivo. 2014 Toxicol. Appl. Pharmacol. pmid:25223693
Li C et al. Influence of mefenamic acid on the intestinal absorption and metabolism of three bioactive flavones in Radix Scutellariae and potential pharmacological impact. 2014 Pharm Biol pmid:24102566
Fong SY et al. Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, wogonin, oroxylin A and their glucuronides baicalin, wogonoside and oroxyloside in rats and its application to brain uptake and plasma pharmacokinetic studies. 2014 J Pharm Biomed Anal pmid:24803030
Sikder MA et al. Inhibition of TNF-α-induced MUC5AC mucin gene expression and production by wogonin through the inactivation of NF-κB signaling in airway epithelial cells. 2014 Phytother Res pmid:23463646
Bak EJ et al. Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice. 2014 Clin Nutr pmid:23623334
Liu J et al. Screening of osteoanagenesis-active compounds from Scutellaria baicalensis Georgi by hPDLC/CMC-online-HPLC/MS. 2014 Fitoterapia pmid:24393619
Fong SY and Zuo Z Species difference in the inhibitory potentials of non-steroidal anti-inflammatory drugs on the hepatic sulfation and glucuronidation of bioactive flavonoids: differential observations among common inhibition parameters. 2014 Xenobiotica pmid:24168065
Gong WY et al. Flavonoid components in Scutellaria baicalensis inhibit nicotine-induced proliferation, metastasis and lung cancer-associated inflammation in vitro. 2014 Int. J. Oncol. pmid:24604573
Wang H et al. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway. 2014 Mol. Carcinog. pmid:23761018
Huang KF et al. [Experimental study on inhibitory effect of wogonin on proliferation and invasion of breast cancer cells]. 2014 Zhongguo Zhong Yao Za Zhi pmid:25039187
Shin HS et al. Skullcap (Scutellaria baicalensis) extract and its active compound, wogonin, inhibit ovalbumin-induced Th2-mediated response. 2014 Molecules pmid:24566319
Yeh CH et al. Wogonin attenuates endotoxin-induced prostaglandin E2 and nitric oxide production via Src-ERK1/2-NFκB pathway in BV-2 microglial cells. 2014 Environ. Toxicol. pmid:23362215
Nam KW et al. The role of wogonin in controlling SOCS3 expression in neuronal cells. 2014 Biochem. Biophys. Res. Commun. pmid:25035930
Zhang F and Wang G A review of non-nucleoside anti-hepatitis B virus agents. 2014 Eur J Med Chem pmid:24549242
Yao J et al. Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway. 2014 Immunology pmid:24766487
Zhang Y et al. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma. 2014 Arch. Toxicol. pmid:23835921
Marsh Z et al. Effect of light, methyl jasmonate and cyclodextrin on production of phenolic compounds in hairy root cultures of Scutellaria lateriflora. 2014 Phytochemistry pmid:25236693
Tian SS et al. Flavonoids from the leaves of Carya cathayensis Sarg. inhibit vascular endothelial growth factor-induced angiogenesis. 2014 Fitoterapia pmid:24096161
Yan T et al. Wogonin modulates hydroperoxide-induced apoptosis via PI3K/Akt pathway in retinal pigment epithelium cells. 2014 Diagn Pathol pmid:25432585
Zhao K et al. Wogonin suppresses melanoma cell B16-F10 invasion and migration by inhibiting Ras-medicated pathways. 2014 PLoS ONE pmid:25203554
Yang H et al. Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells. 2014 Oncotarget pmid:25149543
Yao J et al. NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis. 2014 Cell Death Dis pmid:24901054
Talbi A et al. Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of wogonin in rats. 2014 Molecules pmid:24786691
Xu X et al. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway. 2014 Biochem. Pharmacol. pmid:25264278
Hosseinzadeh Z et al. Effect of TGFβ on Na+/K+ ATPase activity in megakaryocytes. 2014 Biochem. Biophys. Res. Commun. pmid:25168590
Ku SK and Bae JS Antithrombotic activities of wogonin and wogonoside via inhibiting platelet aggregation. 2014 Fitoterapia pmid:25020199
Zhao K et al. Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling. 2014 Eur. J. Pharmacol. pmid:24858369
Qian C et al. Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells. 2014 Free Radic. Res. pmid:24666416
Zhou M et al. Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-κB signaling pathway. 2014 Vascul. Pharmacol. pmid:24534483
Tian J et al. A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects. 2014 Drug Deliv pmid:24215357
Ku SK et al. Inhibitory effect of baicalin, baicalein and wogonin on secretory group IIA phospholipase A2. 2015 Arch. Pharm. Res. pmid:25564337
Woźniak D et al. Antiradical and antioxidant activity of flavones from Scutellariae baicalensis radix. 2015 Nat. Prod. Res. pmid:25427178
Liu J et al. Deep Sequencing of the Scutellaria baicalensis Georgi Transcriptome Reveals Flavonoid Biosynthetic Profiling and Organ-Specific Gene Expression. 2015 PLoS ONE pmid:26317778
Aslan E and Adem S In vitro effects of some flavones on human pyruvate kinase isoenzyme M2. 2015 J. Biochem. Mol. Toxicol. pmid:25388478
Qu JT et al. Vasodilatory Effect of Wogonin on the Rat Aorta and Its Mechanism Study. 2015 Biol. Pharm. Bull. pmid:26632179
Lu H et al. Wogonin inhibits the proliferation of myelodysplastic syndrome cells through the induction of cell cycle arrest and apoptosis. 2015 Mol Med Rep pmid:26398525
Zhang YM et al. Wogonin suppresses osteopontin expression in adipocytes by activating PPARα. 2015 Acta Pharmacol. Sin. pmid:26073326
Xiao W et al. Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity. 2015 J. Immunother. pmid:25962106
Huang Y et al. Wogonin inhibits LPS-induced vascular permeability via suppressing MLCK/MLC pathway. 2015 Vascul. Pharmacol. pmid:25956732
Wang W et al. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro. 2015 Inflamm. Res. pmid:25917044
Hu C et al. Wogonin induces apoptosis and endoplasmic reticulum stress in HL-60 leukemia cells through inhibition of the PI3K-AKT signaling pathway. 2015 Oncol. Rep. pmid:25846394
Persson C Drug-induced death of eosinophils. Promises and pitfalls. 2015 Am. J. Respir. Crit. Care Med. pmid:25767918
Ge W et al. Wogonin Induced Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Human Malignant Neuroblastoma Cells Via IRE1α-Dependent Pathway. 2015 J. Mol. Neurosci. pmid:25740014
Tan CX et al. Activities of wogonin analogs and other flavones against Flavobacterium columnare. 2015 Chem. Biodivers. pmid:25676507
Zhu Y and Wang J Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease. 2015 Neurol. Sci. pmid:25596147
Boozari M et al. Growth inhibition and apoptosis induction by Scutellaria pinnatifida A. Ham. on HL-60 and K562 leukemic cell lines. 2015 Environ. Toxicol. Pharmacol. pmid:25546119
Chen S et al. Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4-MyD88-TAK1-mediated NF-κB and MAPK signaling pathway. 2015 Cell. Mol. Neurobiol. pmid:25504431
Song X et al. Wogonin influences vascular permeability via Wnt/β-catenin pathway. 2015 Mol. Carcinog. pmid:24136474
Yeh CH et al. Protective effect of wogonin on proinflammatory cytokine generation via Jak1/3-STAT1/3 pathway in lipopolysaccharide stimulated BV2 microglial cells. 2015 Toxicol Ind Health pmid:23592745